Company Filing History:
Years Active: 2015
Title: Marcia Nikac: Innovator in Cancer Therapeutics
Introduction
Marcia Nikac is a prominent inventor based in Parkville, Australia. She has made significant contributions to the field of cancer research, particularly through her innovative work on selective FAK inhibitors.
Latest Patents
Marcia holds 1 patent for her invention titled "Selective FAK inhibitors." This patent describes a compound of the formula (I), where R or R is a cycle, an amine group, and R is an aromatic group with a carbonyl-containing substituent for use as a FAK inhibitor. This invention has the potential to advance therapeutic options in cancer treatment.
Career Highlights
Marcia is associated with Cancer Therapeutics CRC Pty Limited, where she applies her expertise in developing novel cancer therapies. Her work is crucial in the ongoing battle against cancer, and her innovative approaches are paving the way for new treatment methodologies.
Collaborations
Marcia collaborates with notable colleagues, including Ian Peter Holmes and Yiva Bergman. These partnerships enhance the research and development efforts within her field, fostering a collaborative environment for innovation.
Conclusion
Marcia Nikac's contributions to cancer therapeutics through her patent on selective FAK inhibitors exemplify her commitment to advancing medical science. Her work continues to inspire and drive progress in the fight against cancer.